First Trust Advisors LP Myriad Genetics Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, First Trust Advisors LP holds 186,376 shares of MYGN stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

186,376

Previous 90,384 106.2%

Holding current value

$2.39 Million

Previous $2.21 Million 130.81%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.97 - $28.6 $2.3 Million - $2.75 Million	95,992 Added 106.2%	186,376 $5.1 Million
Q2 2024 Aug 13, 2024	SELL	$17.98 - $25.47 $473,934 - $671,363	-26,359 Reduced 22.58%	90,384 $2.21 Million
Q1 2024 May 13, 2024	BUY	$17.59 - $23.59 $2.05 Million - $2.75 Million	116,743 New	116,743 $2.49 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $521,525 - $811,680	34,176 New	34,176 $793,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $60,220 - $92,199	3,307 Added 14.1%	26,760 $511,000
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $110,264 - $173,473	-6,703 Reduced 22.23%	23,453 $426,000
Q1 2022 May 13, 2022	SELL	$22.67 - $28.01 $1.2 Million - $1.48 Million	-52,893 Reduced 63.69%	30,156 $760,000
Q4 2021 Feb 08, 2022	BUY	$24.13 - $32.63 $2 Million - $2.71 Million	83,049 New	83,049 $2.29 Million
Q4 2019 Feb 03, 2020	SELL	$20.93 - $35.1 $278,745 - $467,461	-13,318 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$22.08 - $47.08 $294,061 - $627,011	13,318 New	13,318 $381,000
Q2 2019 Jul 30, 2019	SELL	$22.67 - $35.0 $442,790 - $683,620	-19,532 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$26.93 - $34.7 $809,973 - $1.04 Million	-30,077 Reduced 60.63%	19,532 $648,000
Q4 2018 Feb 07, 2019	SELL	$27.23 - $45.56 $1.02 Million - $1.71 Million	-37,484 Reduced 43.04%	49,609 $1.44 Million
Q3 2018 Oct 25, 2018	BUY	$37.57 - $50.34 $2.78 Million - $3.72 Million	73,936 Added 561.95%	87,093 $4.01 Million
Q2 2018 Aug 02, 2018	SELL	$27.75 - $40.17 $661,948 - $958,215	-23,854 Reduced 64.45%	13,157 $492,000
Q1 2018 Apr 23, 2018	BUY	$28.83 - $41.01 $1.07 Million - $1.52 Million	37,011 New	37,011 $1.09 Million
Q4 2017 Feb 08, 2018	SELL	$28.45 - $37.14 $335,141 - $437,509	-11,780 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$24.01 - $36.2 $282,837 - $426,436	11,780	11,780 $426,000

Others Institutions Holding MYGN

# of Institutions

250

Shares Held

90.6M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.03B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Myriad Genetics Inc Transaction History